Argenx
ARGX
#535
Rank
โ‚น4.046 T
Marketcap
โ‚น65,206
Share price
-0.21%
Change (1 day)
28.21%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น836.53. In 2024 the company made an earnings per share (EPS) of โ‚น1,313 an increase over its 2023 EPS that were of -โ‚น486.64.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-40.83%
2024โ‚น1,313-369.77%
2023-โ‚น486.64-60.46%
2022-โ‚น1,23163.33%
2021-โ‚น753.53-40.37%
2020-โ‚น1,264183.47%
2019-โ‚น445.81123.09%
2018-โ‚น199.8454.93%
2017-โ‚น128.9814.07%
2016-โ‚น113.0713.05%
2015-โ‚น100.02-36.34%
2014-โ‚น157.11209.04%
2013-โ‚น50.84-33.99%
2012-โ‚น77.02185.59%
2011-โ‚น26.97